Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia (Q46364104)

21 December 2017

title

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia (English)

1 reference

21 December 2017

0 references

1 reference

1 reference

21 December 2017

author name string

Sara K Olsson

1 reference

21 December 2017

Alexandra S Andersson

1 reference

21 December 2017

Klas R Linderholm

1 reference

21 December 2017

Maria Holtze

1 reference

21 December 2017

Linda K Nilsson-Todd

1 reference

21 December 2017

Lilly Schwieler

1 reference

21 December 2017

Elin Olsson

1 reference

21 December 2017

Kerstin Larsson

1 reference

21 December 2017

Göran Engberg

1 reference

21 December 2017

language of work or name

1 reference

17 September 2008

1 reference

21 December 2017

The International Journal of Neuropsychopharmacology

published in

1 reference

21 December 2017

volume

1 reference

21 December 2017

issue

1 reference

21 December 2017

page(s)

501-512

1 reference

21 December 2017

Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Phencyclidine and the midbrain dopamine system: electrophysiology and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Endogenous kynurenic acid disrupts prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Elevations of endogenous kynurenic acid produce spatial working memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Synaptic regulation of mesocorticolimbic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Increased dopamine transmission in schizophrenia: relationship to illness phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Amphetamine induces dopamine efflux through a dopamine transporter channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Glutamate as a therapeutic target in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Presynaptic kynurenate-sensitive receptors inhibit glutamate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Working memory deficit as a core neuropsychological dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Increased cortical kynurenate content in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Phencyclidine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Kynurenic acid has a dual action on AMPA receptor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

The control of firing pattern in nigral dopamine neurons: single spike firing

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

The control of firing pattern in nigral dopamine neurons: burst firing

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145708009383

1 reference

7 January 2021

Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009383

7 January 2021

10.1017/S1461145708009383

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017